You are here: Home » News-CM » Companies » News
Business Standard

Lupin launches Silodosin Capsules

Capital Market 

announced the launch of Capsules 4mg and 8mg, having received an approval from the (FDA) earlier.

Lupin's Capsules 4mg and 8mg; is the generic equivalent of AIIergan's Rapaflo.

An alpha-l adrenergic receptor antagonist, it is indicated for the of (BPH).

Rapaflo had annual sales of $198.5 million in the US (IQVIA MAT September 2018).

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, December 04 2018. 16:30 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU